These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28112086)

  • 1. Outbreak of carbapenem-resistant Providencia rettgeri in a tertiary hospital.
    Tshisevhe VS; Lekalakala MR; Tshuma N; Janse van Rensburg S; Mbelle N
    S Afr Med J; 2016 Dec; 107(1):31-33. PubMed ID: 28112086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of multidrug-resistant Providencia rettgeri isolates co-producing NDM-1 carbapenemase and PER-1 extended-spectrum β-lactamase causing a first outbreak in Korea.
    Shin S; Jeong SH; Lee H; Hong JS; Park MJ; Song W
    Ann Clin Microbiol Antimicrob; 2018 May; 17(1):20. PubMed ID: 29728111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit.
    Zavascki AP; Carvalhaes CG; da Silva GL; Tavares Soares SP; de Alcântara LR; Elias LS; Sandri AM; Gales AC
    Infect Control Hosp Epidemiol; 2012 Jun; 33(6):627-30. PubMed ID: 22561721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
    Oikonomou O; Liakopoulos A; Phee LM; Betts J; Mevius D; Wareham DW
    Microb Drug Resist; 2016 Jul; 22(5):379-86. PubMed ID: 27380549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China.
    Jiang AM; Shi X; Liu N; Gao H; Ren MD; Zheng XQ; Fu X; Liang X; Ruan ZP; Yao Y; Tian T
    BMC Infect Dis; 2020 Jun; 20(1):452. PubMed ID: 32600270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia.
    Novak A; Goic-Barisic I; Andrasevic AT; Butic I; Radic M; Jelic M; Rubic Z; Tonkic M
    Microb Drug Resist; 2014 Oct; 20(5):399-403. PubMed ID: 24716493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors.
    Maldonado N; Castro B; Berrio I; Manjarrés M; Robledo C; Robledo J
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):511-515. PubMed ID: 26778651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
    Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
    PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases.
    Pang F; Jia XQ; Wang B; Li YH; Zhao QG
    Pathol Biol (Paris); 2014 Jun; 62(3):152-5. PubMed ID: 24685523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
    Goodman KE; Simner PJ; Tamma PD; Milstone AM
    Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital.
    Choi HK; Kim YK; Kim HY; Park JE; Uh Y
    Korean J Intern Med; 2015 Mar; 30(2):219-25. PubMed ID: 25750564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope.
    Chang CL; Su LH; Lu CM; Tai FT; Huang YC; Chang KK
    J Hosp Infect; 2013 Oct; 85(2):118-24. PubMed ID: 23954065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
    Baran I; Aksu N
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():20. PubMed ID: 27048322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic prescription in intensive care units in Latin America.
    Curcio DJ;
    Rev Argent Microbiol; 2011; 43(3):203-11. PubMed ID: 22430995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
    Hyle EP; Ferraro MJ; Silver M; Lee H; Hooper DC
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1242-9. PubMed ID: 21029005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis of a multidrug-resistant clinical Providencia rettgeri (PR002) strain with the novel integron ln1483 and an A/C plasmid replicon.
    Mbelle NM; Osei Sekyere J; Amoako DG; Maningi NE; Modipane L; Essack SY; Feldman C
    Ann N Y Acad Sci; 2020 Feb; 1462(1):92-103. PubMed ID: 31549428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.
    Cheon S; Kim MJ; Yun SJ; Moon JY; Kim YS
    Korean J Intern Med; 2016 Mar; 31(2):367-74. PubMed ID: 26874513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
    Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
    J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.